topic adverse-events-and-recalls 
Pharma Leaders
APRIL 4, 2023
Camber Pharmaceuticals has recalled one lot of Atovaquone oral suspension, USP 750mg/5mL because of the possible contamination with Bacillus cereus — bacteria found in soil, plants and food. The affected lot was distributed nationwide, but the company has not received any reports of adverse events related to the issue.
FDA Law Blog: Biosimilars
MARCH 21, 2024
As the new law unfolds—and as state laws regarding ingredients and packaging, as well as laws regarding environmental claims continue to affect the cosmetics and personal care industries—the topics covered at the conference have never been more relevant. As readers of our blog know, MoCRA was a significant change to regulation of cosmetics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 11, 2023
This is, you may recall, our treasured signal to daydream about weekend plans. The agency received a “few” adverse event reports about compounded versions of the medicines and the warning raised an important question: To what extent should the public be concerned? Not a moment too soon, yes? And what about you?
RX Note
FEBRUARY 23, 2023
Introduction The purpose of this table of contents is to enable you to know clearly which topics are available in the blog, hence easing your learning process. Alternatively, you can also use the search feature at the top right corner. Ancora imparo: I am still learning. insulins, inhalers, GTN, transdermal patches, etc.)
Expert insights. Personalized for you.
52 
Let's personalize your content